Announced Tue, 21 Jul · 16:58 IST
Reg 74(5) compliance certificate filed for Q1 FY27
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+14.1%1-day move
₹32.00
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+14.1+12.5+11.7+9.4——————
Up moveDown movePending
AI summary
ANG Lifesciences India has submitted the Regulation 74(5) certificate from its Registrar and Transfer Agent, Bigshare Services, for the quarter ended June 30, 2026. The certificate confirms that securities received for dematerialisation were processed and listed on BSE, and that physical share certificates were mutilated and cancelled within 15 days. This is a routine quarterly compliance filing with no material business or financial implications.
Likely market impact
Routine procedural compliance filing; no material impact on shareholders or stock price.